Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

VALIDITY OF ANN-ARBOR STAGING CLASSIFICATION FOR NON-HODGKINS LYMPHOMAS CANCER TREATMENT REPORTS Rosenberg, S. A. 1977; 61 (6): 1023-1027

Abstract

The Ann Arbor staging classification has proved to be valuable for Hodgkin's disease. When proposed in 1971 it was thought that it could also be applied to the non-Hodgkin's lymphomas. The diversity of the non-Hodgkin's groups, the continued evolution of histopathologic classifications, and the great frequency of advanced disease in the lymphocytic subgroups make the Ann Arbor classification of only limited value for the non-Hodgkin's lymphomas.

View details for Web of Science ID A1977DX62400012

View details for PubMedID 902260